Dorn J - Search Results

1

Geriatric assessment and biomarkers in patients with metastatic breast cancer receiving first-line mono-chemotherapy: Results from the randomized phase III PELICAN trial.

Honecker F, Harbeck N, Schnabel C, Wedding U, Waldenmaier D, Saupe S, Jäger E, Schmidt M, Kreienberg R, Müller L, Otremba B, Dorn J, Warm M, Al-Batran SE, de Wit M; PELICAN investigators. Honecker F, et al. Among authors: dorn j. J Geriatr Oncol. 2018 Mar;9(2):163-169. doi: 10.1016/j.jgo.2017.09.009. Epub 2017 Oct 18. J Geriatr Oncol. 2018. PMID: 29055624 Clinical Trial.

2

Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma.

Dorn J, Harbeck N, Kates R, Magdolen V, Grass L, Soosaipillai A, Schmalfeldt B, Diamandis EP, Schmitt M. Dorn J, et al. Biol Chem. 2006 Aug;387(8):1121-8. doi: 10.1515/BC.2006.138. Biol Chem. 2006. PMID: 16895483

3

Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients.

Dorn J, Schmitt M, Kates R, Schmalfeldt B, Kiechle M, Scorilas A, Diamandis EP, Harbeck N. Dorn J, et al. Clin Cancer Res. 2007 Mar 15;13(6):1742-8. doi: 10.1158/1078-0432.CCR-06-2482. Clin Cancer Res. 2007. PMID: 17363527

4

Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer.

Dorn J, Harbeck N, Kates R, Gkazepis A, Scorilas A, Soosaipillai A, Diamandis E, Kiechle M, Schmalfeldt B, Schmitt M. Dorn J, et al. Ann Oncol. 2011 Apr;22(4):877-883. doi: 10.1093/annonc/mdq462. Epub 2010 Oct 5. Ann Oncol. 2011. PMID: 20924077 Free article.

5

Circulating biomarker tissue kallikrein-related peptidase KLK5 impacts ovarian cancer patients' survival.

Dorn J, Magdolen V, Gkazepis A, Gerte T, Harlozinska A, Sedlaczek P, Diamandis EP, Schuster T, Harbeck N, Kiechle M, Schmitt M. Dorn J, et al. Ann Oncol. 2011 Aug;22(8):1783-90. doi: 10.1093/annonc/mdq701. Epub 2011 Jan 27. Ann Oncol. 2011. PMID: 21273346 Free article.

6

Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.

Schmitt M, Harbeck N, Brünner N, Jänicke F, Meisner C, Mühlenweg B, Jansen H, Dorn J, Nitz U, Kantelhardt EJ, Thomssen C. Schmitt M, et al. Among authors: dorn j. Expert Rev Mol Diagn. 2011 Jul;11(6):617-34. doi: 10.1586/erm.11.47. Expert Rev Mol Diagn. 2011. PMID: 21745015 Review.

7

OVSCORE - a validated score to identify ovarian cancer patients not suitable for primary surgery.

Dorn J, Bronger H, Kates R, Slotta-Huspenina J, Schmalfeldt B, Kiechle M, Diamandis EP, Soosaipillai A, Schmitt M, Harbeck N. Dorn J, et al. Oncol Lett. 2015 Jan;9(1):418-424. doi: 10.3892/ol.2014.2630. Epub 2014 Oct 24. Oncol Lett. 2015. PMID: 25436002 Free PMC article.

8

A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study.

Harbeck N, Saupe S, Jäger E, Schmidt M, Kreienberg R, Müller L, Otremba BJ, Waldenmaier D, Dorn J, Warm M, Scholz M, Untch M, de Wit M, Barinoff J, Lück HJ, Harter P, Augustin D, Harnett P, Beckmann MW, Al-Batran SE; PELICAN Investigators. Harbeck N, et al. Among authors: dorn j. Breast Cancer Res Treat. 2017 Jan;161(1):63-72. doi: 10.1007/s10549-016-4033-3. Epub 2016 Oct 31. Breast Cancer Res Treat. 2017. PMID: 27798749 Free PMC article. Clinical Trial.

9

PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients.

Absmaier M, Napieralski R, Schuster T, Aubele M, Walch A, Magdolen V, Dorn J, Gross E, Harbeck N, Noske A, Kiechle M, Schmitt M. Absmaier M, et al. Among authors: dorn j. Int J Oncol. 2018 Mar;52(3):755-767. doi: 10.3892/ijo.2018.4241. Epub 2018 Jan 8. Int J Oncol. 2018. PMID: 29328369 Free PMC article.

10

Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker.

Scorilas A, Borgoño CA, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M, Diamandis EP. Scorilas A, et al. Among authors: dorn j. J Clin Oncol. 2004 Feb 15;22(4):678-85. doi: 10.1200/JCO.2004.05.144. J Clin Oncol. 2004. PMID: 14966091

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters